Compare DSX & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DSX | STXS |
|---|---|---|
| Founded | 1999 | 1990 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.0M | 210.0M |
| IPO Year | 2005 | 2004 |
| Metric | DSX | STXS |
|---|---|---|
| Price | $1.66 | $2.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 578.1K | 409.8K |
| Earning Date | 11-20-2025 | 11-11-2025 |
| Dividend Yield | ★ 2.41% | N/A |
| EPS Growth | ★ 231.99 | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $218,560,000.00 | $30,075,000.00 |
| Revenue This Year | N/A | $24.21 |
| Revenue Next Year | $11.40 | $29.83 |
| P/E Ratio | $11.03 | ★ N/A |
| Revenue Growth | N/A | ★ 19.62 |
| 52 Week Low | $1.27 | $1.54 |
| 52 Week High | $2.04 | $3.59 |
| Indicator | DSX | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 38.39 | 41.72 |
| Support Level | $1.67 | $2.25 |
| Resistance Level | $1.73 | $2.48 |
| Average True Range (ATR) | 0.06 | 0.09 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 4.78 | 15.25 |
Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation, the services provided by the vessels are similar and all operate under the same economic environment.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.